The short version of Freeze-thaw cycling fits in a sentence. The long version — which is the one that helps — is below.
Reviewed 2025-10-07. Anything still debated is marked as such rather than presented as settled.
At the molecular level, ipamorelin acts as an agonist at the growth hormone secretagogue receptor type 1a, the same G protein-coupled receptor that binds ghrelin. Receptor activation couples to Gq/11 signaling, raising intracellular calcium through inositol trisphosphate and diacylglycerol, which in turn promotes exocytosis of growth hormone from pituitary somatotroph cells. Ipamorelin binds this receptor with high affinity and shows weak activity at other secretagogue-related targets in vitro. Its action requires the intact receptor and is not reversed by growth hormone-releasing hormone antagonists.
Compared with earlier growth hormone secretagogues such as GHRP-6 and hexarelin, ipamorelin has been reported to produce less stimulation of adrenocorticotropic hormone, cortisol, and prolactin in animal and early human studies. This selectivity is usually attributed to differences in receptor subtype interactions and to the tissue distribution of the receptor. Effects on appetite appear weaker than those of ghrelin itself, although the supporting evidence base is small. Whether these differences produce a distinct clinical profile remains an open question, since controlled human trials are limited.
Purity assessment for this peptide relies mainly on reversed-phase high-performance liquid chromatography. A C18 column with a water-acetonitrile gradient containing trifluoroacetic acid separates the target from truncated sequences and oxidation products. Detection near 214 nm exploits the amide backbone, while the aromatic side chains allow additional monitoring close to 280 nm. Reported purity values depend on the method, so a certificate of analysis carries weight only when gradient, column and integration parameters are given.
Mass spectrometry confirms identity and reveals structural deviations that chromatography alone can miss. Positive-mode electrospray ionisation generally yields multiply charged ions whose deconvoluted mass is checked against the theoretical value. Amino acid analysis, and enzymatic digestion with subsequent fragment mapping, provide independent confirmation of sequence and of the terminal amide. Analysts take care to separate the target from deletion sequences, which may differ by one residue and therefore by only a small mass increment.
The lyophilised solid is normally held at -20 °C or colder, shielded from light and moisture. Stability in that state is measured in years, although shelf life depends on residual water content and the container seal. Once dissolved, the peptide is more fragile: aqueous solutions are commonly kept at 2-8 °C and used within days to weeks, and repeated freeze-thaw cycling is avoided. Strongly acidic or basic conditions accelerate hydrolysis, and prolonged exposure to them can strip the terminal amide.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C38H49N9O5 | Pentapeptide with amidated C-terminus |
| Molecular weight | 711.85 g/mol | Monoisotopic mass |
| Primary receptor | GHS-R1a | Ghrelin receptor, Gq/11 coupled |
| Peptide class | Synthetic pentapeptide | Contains two non-natural residues |
| Reported selectivity | Lower cortisol and prolactin effect | Observed in animal and early human work |
Long-term storage of the dry powder is typically at minus twenty degrees Celsius or lower, protected from light and moisture. Solutions are commonly kept frozen and thawed only once, because repeated freeze-thaw cycles can promote aggregation and loss of measurable peptide content. Buffers near neutral pH are preferred over strongly acidic or strongly basic conditions. Shipping at ambient temperature is acceptable for short periods when the powder remains sealed and desiccated.
Identity and purity are assessed by complementary methods rather than a single test. Reversed-phase high-performance liquid chromatography separates the peptide from related impurities and reports a percentage purity. Mass spectrometry, most often with electrospray ionization, confirms the expected molecular mass and detects sequence-related variants. Amino acid analysis can verify composition, while water content and residual counterion measurements support the mass balance of a batch. Stability studies under accelerated conditions are used to estimate shelf life, though such estimates carry uncertainty for long-term storage.
Material supplied for research use is normally a white to off-white lyophilized powder. The solid is hygroscopic and is handled in a low-humidity environment to limit water uptake. Bulk quantities are frequently shipped in sealed vials under inert gas. Once reconstituted in water or a neutral buffer, the solution is less stable than the dry powder and is usually divided into single-use aliquots.
Ipamorelin is a synthetic pentapeptide classified as a growth hormone secretagogue. Its sequence, Aib-His-D-2-Nal-D-Phe-Lys-NH2, combines three non-proteinogenic residues with a C-terminal amide. The N-terminal aminoisobutyric acid unit and the two aromatic D-amino acids distinguish it from peptides assembled only from standard L-amino acids. Its formula is C38H49N9O5, corresponding to an average mass near 711.9 Da. At neutral pH the molecule carries a net positive charge, a property that shapes its behaviour in chromatographic and electrophoretic systems.
The compound was developed at Novo Nordisk during the 1990s as part of a programme seeking secretagogues with improved selectivity. It was described in the peer-reviewed literature in 1998 alongside related pentapeptides from the same series. Investigators advanced it because it raised growth hormone output in animal models while leaving other pituitary hormones comparatively unaffected. The development code NNC 26-0161 appears in earlier reports, and ipamorelin later became the common designation in published work.
Selectivity is the property most often attached to this peptide. Published animal and early human studies record increases in growth hormone release after administration, with adrenocorticotropic hormone and cortisol responses remaining small by comparison. Effects on appetite-related pathways also appear weaker than those reported for several earlier secretagogues. Reviews that compare members of the growth hormone secretagogue family cite these findings frequently, though the receptor-level explanation for the selectivity continues to be debated rather than settled.
Type I: Properdin levels are unable to be detected Type II: Properdin levels are from 1-10% in comparison to normal levels; function is intact Type III: Properdin levels are normal but the function is absent Evaluations for properdin deficiency may take place in patients with frequenct Neisserial infections with a functioning classical complement pathway (CH50). The AH50 assay is based on the lysis of unsensitized rabbit erythrocytes, however, normal results have been reported in patients with Type I properdin deficiency. Family history of X-linked inheritance should be considered. Further testing includes: Factor D Function by Hemolytic Assay, Properdin Level by ELISA, and gene sequencing to detect mutations for confirmation. Patients with Factor D deficiency or properdin deficiency are advised to receive meningococcal vaccinations and frequent evaluations for meningococcal antibodies. For those with recurring infections, prophylactic antibiotics are administered.
== Chromatography == Along with its medical applications, hydroxyapatite is also used in downstream applications under mixed-mode chromatography in polishing step. The ions present on the surface of hydroxyapatite make it an ideal candidate with unique selectivity, separation and purification of biomolecule mixtures. In mixed-mode chromatography, hydroxyapatite is used as the stationary phase in chromatography columns. The combined presence of calcium ions (C- sites) and phosphate sites (P-sites) provide metal affinity and ion exchange properties respectively. The C-sites on the surface of the resin undergo metal affinity interactions with phosphate or carboxyl groups present on the biomolecules. Concurrently, these positively charged C-sites tend to repel positively charged functional groups (e.g., amino groups) on biomolecules. P-sites undergo cationic exchange with positively charged functional groups on biomolecules. They exhibit electrostatic repulsion with negatively charged functional groups on biomolecules. For the elution of molecules buffer with high concentration of phosphate and sodium chloride is used. The nature of different charged ions on the surface of hydroxyapatite provides the framework for unique selectivity and binding of biomolecules, facilitating robust separation of biomolecules. Hydroxyapatite is available in different forms and in different sizes for the purpose of protein purification. The advantages of hydroxyapatite media are its high product stability and uniformity in various lots during its production.
Narrated by Paul Brightwell, produced by David Sington, directed by David McNab, made by Dox Productions 4 March The Engines That Came in from the Cold, about the Russian N1 rocket with an unexpected and surprising outcome to the documentary, and a reference to the 1963 book The Spy Who Came in from the Cold; George Mueller, head of Apollo programme from 1963 to 1969; Charles Vick of the Federation of American Scientists; Sergei Korolev, chief designer at OKB-1; Vasily Mishin, deputy chief designer at OKB-1, had done calculations showing that to get a cosmonaut on the Moon, it required a 100 tonne vehicle in orbit, which would require a 2,000 tonne vehicle at lift-off; Valentin Anisimov, chief designer at Kuznetsov Design Bureau, and how Korolev approached the Kuznetsov company, to make the new rocket engines for the proposed N1 rocket launcher, but it was too new and large to develop from scratch, so thirty pre-existing engines would be deployed, and the pre-burner which powered the rocket pumps would become a closed cycle, to improve power by 25%, but this was vastly untested; the first twelve launches would be uncrewed, followed by two test crewed launches, and the Soviet limited budget meant that development was not at a sufficient stage (that NASA would have arrived at) before the launches were carried out; this first uncrewed launch took place on 21 February 1969, and one minute into the flight, the rocket exploded; the N1 had a thrust of 4,500 tonnes at launch; the N1 second launch took place on 3 July 1969, after the engine control system was modified, and a few seconds after launch the engine cut out, and the whole N1 launcher fell onto the launch pad, causing total catastrophic results - this explosion stopped any further Soviet Union attempt to reach the Moon with a crewed rocket, the launch pad damage was unrecoverable; two weeks later Apollo 11 landed on the Moon; the N1 next launch was on 26 June 1971, with a rebuilt launch pad, and this launch exploded one minute into the flight; the fourth launch of the N1 on 23 November 1972 exploded two minutes into the flight; by the mid-1970s the Kuznetsov NK-33 closed-cycle engine, for the N1, had been sufficiently tested in its development lifetime; the Soviet Moon mission was around four years behind NASA, and when the engines were finally sufficiently tested, the whole Soviet Moon programme was stopped in 1974; any N1 engines and systems were instructed to be removed, to eliminate its knowledge; only in the early 1990s did knowledge of the N1 first appear; Bob Ford of Lockheed Martin and Bill Hoffman of Aerojet; Kuznetsov had nonetheless kept around sixty NK-33 engines in Samara - the home of Soviet rocketry, and wanted to show these engines to visitors from Aerojet; after a successful test of an NK-33 at Sacramento in October 1995, the NK-33 was developed into the RD-180, which powered the American Lockheed Martin Atlas III rocket; John Karas, of Lockheed Martin, at the first launch of an American rocket, on 24 May 2000 of the Eutelsat 36A satellite, that was powered by a Russian engine - the RD-180, which was twice as powerful as the NK-33, and one engine could replace five engines of the previous Atlas II; Vladimir Chvanov and Boris Katorgin, designers at NPO Energomash; the American rocket engineers had viewed the closed-cycle method as far too dangerous, and it was dangerous, but Russian engineers had developed new stainless steel alloys to largely overcome this danger. Narrated by Jaye Griffiths, produced by Hamish Barbour, directed by, made by Ideal World Productions 17 June The Day the Oceans Boiled, about the Earth's environment; 55 million years ago, the Earth was 6C hotter than it is now, with no ice caps, and trees grew at Antarctica, the temperature became 8C hotter, known as the Paleocene-Eocene Thermal Maximum; mammals shrunk in how large; since 55m years ago, carbon dioxide has been absorbed by plants, cooling the Earth; climate models were derived from weather forecast models; Peter Cox (climatologist) of the Met Office, and carbon sinks, and how each year 6 billion tonnes of carbon dioxide enters the atmosphere, but the effect appears to be only from around 3 billion tonnes; Antonio Nobre of the National Institute of Amazonian Research - he found that the Amazon forest, and its 500 million hectares of trees, was a much bigger carbon sink than presumed - it could be absorbing three-quarters of the carbon dioxide of all the world's vehicles; the Greenland Ice Sheet Project, and Geoffrey Hargreaves at the National Science Foundation Ice Core Facility (NICL) in Colorado, and ice cores from the Vostok Station; the Earth has warmed and cooled in a 100,000 years cycle; the Met Office model predicted that after 2050, due to shortage of rainfall seasons, the Amazon forest would not act as a carbon sink; Carlos Nobre (scientist) and dry seasons, and the possible danger of fire, caused by changes in the tropical climate; Richard Corfield (scientist); Philip D. Gingerich of the University of Michigan; Santo Bains was researching the Paleocene-Eocene boundary, so went to the Gulf Coast Repository, and looked at Core 690 drilled by JOIDES Resolution of the Ocean Drilling Program from the Weddell Sea, and concluded that rapid changes in Earth temperature came from methane clathrates (methane hydrates); geologist Euan Nisbet; the Earth returned to lower temperatures after 60,000 years. Narrated by Matthew Zajac, directed by David Sington, made by Dox Productions 24 June The Fish That Time Forgot, about the coelacanth; Margery Courtney Latimer in 1938 of the Natural History Museum, London, and a fish caught at East London; J. L. B. Smith, from Grahamstown, of Rhodes University; the American Museum of Natural History; evolutionary biologist John McCusker; the Comoro Islands, run by the French, near Madagascar, where another fish was found in 1952; Mike Ruton; Robin Stobbs; the JAGO (German research submersible) and Hans Fricke of the Max Planck Institute for Behavioral Physiology, who found a live fish on 17 January 1987; Susan Jewett of the National Museum of Natural History in Washington; on 30 July 1998, a live female fish is found on a beach in Indonesia by Mark Erdmann. Narrated by Robert Lindsay, produced by Ron Ackerman, directed by Celia Lowenstein, made by Diverse Productions with Nova 8 July The Secret Life of the Mouse, about the laboratory mouse; zoologist Sam Berry of UCL; mouse geneticist Jo Peters of MRC Harwell; Irving Weissman; most genetic research is done with mice, with 25 million a year; Steve Brown, Director of MRC Harwell; the mouse has 99.9% of the genes of humans; the Jackson Laboratory has 1m mice and around 1,000 human staff, with 2,500 strains of mice, who have mouse models of human diseases, and mice breed much quicker than humans do; Beverly Paigen; in one year, there are three generations of mice; twenty Nobel prizes have depended on mouse research; Cliffe Rosen of the Maine Center of Osteoporosis Research; scientists want mutant mice for each gene; Charles Vacanti of the University of Massachusetts Medical School, whose cartilage research led to a mouse having an artificial cartilage human ear grown on its back; Philip Leder of Harvard Medical School, who placed a patent on a mouse; a fluorescent mouse; Hank Greely of Stanford University; it ends with the opening lines from A Tale of Two Cities. Narrated by Stephen Fry, produced by David Paterson, directed by Kevin Hull, made by BOA 2001. The documentary has overtones of the music video of the 2001 Where's Your Head At, made in the same year as the documentary 15 July Saving the Leaning Tower, a documentary chronicling the dramatic rescue of one of the world’s most iconic landmarks. By the late 1980s, the Leaning Tower of Pisa was on the brink of collapse, its southward tilt increasing steadily and threatening catastrophic failure. Alarm spread after the sudden fall of a medieval bell tower in Pavia in 1989, which convinced authorities to close Pisa’s monument to the public. An international committee of engineers, geologists, and historians was formed to save the tower, among them British civil engineer John Burland. Through detailed investigation, the team uncovered the structural weaknesses behind the marble façade and the unstable soils beneath Pisa. Computer models showed the tower should already have collapsed. Temporary steel tendons and 600 tonnes of lead counterweights prevented immediate disaster, but the tower’s fate remained uncertain. Burland proposed a novel, delicate solution: controlled “soil extraction” below the northern side to allow the tower to gently tilt back to stability. The project was plagued by risks, political disputes, and near-disasters, including the “Black September” of 1995, when freezing the foundations caused the tower to lurch alarmingly. Despite opposition, the soil extraction method was eventually approved in 1998. Over two years, engineers removed around 70 tonnes of soil, gradually reducing the lean by half a meter without visible alteration to the monument. By June 2001, the tower had been successfully stabilized, restored to the inclination it had in the 18th century, and reopened to the public. The operation was hailed as one of the greatest feats of modern civil engineering, ensuring the survival of Pisa’s unique heritage for centuries to come. The documentary presents not only the technical challenges but also the cultural, historical, and emotional significance of preserving this medieval masterpiece. 13 October Battle of the Robots: The Hunt for AI, about the work of Hugo de Garis, Rodney Brooks, and Steve Grand (roboticist); the documentary opens with the archetypal and iconic robot HAL 9000 from the 1968 2001: A Space Odyssey (film) and The Blue Danube; Igor Aleksander, who worked in neural systems at Imperial College London, and his views on the likelihood of computational intelligence; Dan Dennett; British roboticist Steve Grand, of North Somerset made the world's first AI computer game Creatures in 1996, and was designing a glider that could teach itself; Blay Whitby of the University of Sussex; the MIT Computer Science and Artificial Intelligence Laboratory and Brian Scassellati, who was designing a social robot called Cog (project); Belgian Walter De Brouwer of Starlab in Belgium; engineer Kevin Warwick of the University of Reading at the 2001 Royal Society Prizes for Science Books (Aventis Prize for Science Books), won by Robert Kunzig. Narrated by Patrick Forbes, produced by Nicolas Kent 28 October Bioterror, an Equinox Special, about biological weapons, with Judith Miller and her 2001 book Germs: Biological Weapons and America's Secret War; Robert Kadlec of the National War College; science writer William Broad; the ATCC in Manassas, Virginia; microbiologist William C. Patrick III; the 2001 anthrax attacks; microbiologist Richard O. Spertzel; geneticist Matthew Meselson; Gennady Lepyoshkin, Director from 1987 to 2001 of a Russian secret biological research site; Jonathan B. Tucker; Chris Shays; Andrew C. Weber; Sergei Popov (bioweaponeer) had worked at the State Research Center for Applied Microbiology in Obolensk, Moscow Oblast. Produced by Matthew Collins, directed by Kirk Wolfinger, made by WGBH. Shown on Tuesday 20 November 2001 on The Nature of Things in Canada, and on Nova, and on Nova on Tuesday 13 November 2001
Sources: en.wikipedia.org
His work has also examined the changing role of behavioral treatment when used with GLP-1 medications, as well as the psychiatric safety of the new drugs. With colleague Gary Foster, Wadden developed the Weight and Lifestyle Inventory (WALI), a widely used self-report tool for obesity assessment, including in bariatric surgery programs. He has published more than 500 refereed papers and 40 book chapters, and co-edited seven books, including Handbook of Obesity Treatment. Since 2020, he has been recognized by Clarivate as a Highly Cited Researcher across multiple fields.
== L == Lamina A layer of neurons in a neural structure. In the spinal cord and cerebral cortex, laminae are functionally and anatomically distinct. Lateral geniculate nucleus (LGN) A relay center in the thalamus that receives input from the retina and sends visual information to the visual cortex. Lateral inhibition A neural mechanism in which an excited neuron reduces the activity of its neighbors. Enhances contrast in sensory systems such as vision and touch. Lateral sulcus A deep groove in the cerebral cortex that separates the frontal lobe and parietal lobe from the temporal lobe. Learning The acquisition of new knowledge or skills through experience, study, or teaching. In neuroscience, learning is linked to synaptic plasticity and neural circuit changes. Learning A neurobiological process through which experience induces lasting changes in the nervous system, leading to the acquisition or modification of behavior, knowledge, or skills. Lentiform nucleus A structure within the basal ganglia composed of the putamen and globus pallidus, involved in motor control and learning. Lesion Damage or abnormal change in brain tissue, caused by injury, stroke, disease, or surgery. Lesion studies are used to investigate brain function. Levodopa A precursor to dopamine used in the treatment of Parkinson’s disease. It crosses the blood–brain barrier and is converted to dopamine in the brain. Limbic system A group of interconnected brain structures involved in emotion, motivation, memory, and olfaction. Includes the amygdala, hippocampus, and cingulate cortex.
== Tissue distribution == Studies have detected FFAR2 protein and/or its messenger RNA (an indicator of FFAR2 protein expression) in the following cell types, cell lines, and tissues: 1) human and rodent enteroendocrine K cells, i.e., cells located in the epithelium of the small intestine; 2) human and rodent enteroendocrine L cells, i.e., cells located in the epithelium of the small intestine and colon; 3) human and rodent fat tissue and/or cultured fat cells; 4) cells in human and rodent pancreatic islets (these islets contain the beta cells and alpha cells that synthesize and secrete insulin and glucagon, respectively, into the blood); 5) cells in and/or derived from cells in the human or mouse spleen, lymph nodes, bone marrow, and blood (e.g., monocytes, lymphocytes, and neutrophils); 6) mouse and, based on indirect studies, human dendritic cells; 7) cells in or derived from cells in human and/or rodent kidneys, hearts, brains (e.g., hypothalamus), fetal membranes, and placentas; 8) cells in the taste buds' lingual papillae of human tongues; 9) mouse renal arteries, aortas, and iliac arteries; 10) various human cell lines including SW480, SW620, HT-29, and T84 colon cancer cells, NCI-H716 colon cancer cells that have a lymphoblast morphology, Caco-2 colorectal cancer cells, Hutu-80 duodenal cancer cells, SW872 liposarcoma cells, MDA-MB-231, MDA-MB-436, and MCF7 breast cancer cells, Huh7 and JHH-4 liver cancer cells, THP-1 acute myeloid leukemia cells, U937 acute promyelocytic leukemia cells, and K562 myelogenous leukemia cells; and 11) the various mouse and rat cell lines discussed below. FFAR2 is also expressed in a wide range of tissues in other animals such as cows, pigs, sheep, cats, and dogs.
The outermost wall of the organ is known as the parietal layer The skin of the organ is known as the visceral layer. The organs have specialized names for their visceral fasciae. In the brain, they are known as meninges; in the heart they are known as pericardia; in the lungs, they are known as pleurae; and in the abdomen, they are known as peritonea. Visceral fascia is less extensible than superficial fascia. Due to its suspensory role for the organs, it needs to maintain its tone rather consistently. If it is too lax, it contributes to organ prolapse, yet if it is hypertonic, it restricts proper organ motility.
Sources: en.wikipedia.org
It is a synthetic pentapeptide belonging to the growth hormone secretagogue family. Its principal characterized target is the ghrelin receptor, also called GHS-R1a. The molecule contains non-natural amino acids and an amidated C-terminus.
Both act at the same G protein-coupled receptor, but ipamorelin is a short synthetic peptide with modified residues rather than the natural 28-amino-acid hormone. Reports describe weaker effects on appetite and on cortisol or prolactin release than those seen with ghrelin. Its resistance to enzymatic breakdown also differs from that of the natural ligand.
Receptor binding and downstream calcium signaling are well characterized in cell-based systems. Effects measured in whole organisms are less consistent across studies and species. The extent to which selective receptor behavior drives the observed hormonal profile is still debated.
Results are most often expressed as a percentage of total peak area from a reversed-phase separation. That figure reflects the detection wavelength, gradient and integration choices used by the laboratory. Two valid certificates can therefore quote different values for the same material without either being incorrect.